Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: A promising strategy?

Immunotherapy

Volumn 5, Issue 10, 2013, Pages 1039-1042

  Garcia Marquez, Maria A ^a   Shimabukuro Vornhagen, Alexander ^a   Theurich, Sebastian ^a   Von Bergwelt Baildon, Michael ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

autologous stem cell transplantation; dendritic cells; fusion vaccine; immunotherapy; multiple myeloma

Indexed keywords

B7 ANTIGEN; BORTEZOMIB; CANCER VACCINE; CD38 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LENALIDOMIDE; MUCIN 1; SYNDECAN 1; THALIDOMIDE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUSION; COHORT ANALYSIS; DISEASE SEVERITY; DRUG TOLERABILITY; FLOW CYTOMETRY; HUMAN; IMMUNOGENICITY; MAINTENANCE CHEMOTHERAPY; MULTIPLE MYELOMA; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REGULATORY T LYMPHOCYTE; STEM CELL MOBILIZATION; TREATMENT RESPONSE; TUMOR IMMUNITY;

CANCER VACCINES; DENDRITIC CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MULTIPLE MYELOMA;

EID: 84885232172     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.96     Document Type: Article

References (15)

1. Zahradova L, Mollova K, Ocadlikova D et al. Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma-Phase II study results. Neoplasma 59(4), 440-449 (2012).
2. Rajkumar SV. Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 86(1), 57-65 (2011).
3. Richardson P, Mitsiades C, Schlossman R et al. The treatment of relapsed and refractory multiple myeloma. Hematology 2007(1), 317-323 (2007).
4. Björkstrand BB, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 88(12), 4711-4718 (1996).
5. Rosenblatt J, Vasir B, Uhl L et al. Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma. Blood 117(2), 393-402 (2011).
6. Rosenblatt J, Avivi I, Vasir B et al. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients. Clin. Cancer Res. 19(13), 3640-3648 (2013).
7. Koido S, Homma S, Okomoto M et al. Fusion between dendritic cells and whole tumor cells as anticancer vaccines. Oncoimmunology 2(5), e244371-e244373 (2013).
8. Rosenblatt J, Kufe D, Avigan D. dendritic cell fusion vaccines for cancer immunotherapy. Expert Opin. Biol. Ther. 5(5), 703-715 (2005).
9. Wang J, Saffold S, Cao X, Krauss J, Chen W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161(10), 5516-5524 (1998).
10. Koido S, Tanaka Y, Cgen D, Kufe D, Gong J. The kinetics of in vivo priming of CD4+ and CD8 T cells by dendritic/tumor fusion cells in MUC-1 transgenic mice. J. Immunol. 168(5), 2111-2117 (2002).
11. Bendandi M, Gocke CD, Kobrin CB et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat. Med. 5(10), 1171-1177 (1999).
12. Dudley ME, Wunderlich JR, Robbins PF et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594), 850-854 (2002).
13. Luptakova KG, Mills H, Stroopinski D et al. Lenalidomine decreases PD-1 expression, depletes regulatory T-cells and improves cellular response to a multiple myeloma/dendritic cell fusion vaccine in vitro. Blood 116, Abstract 2866 (2010).
14. Koido S Homma S, Hara E et al. Regulation of tumor immunity by tumor/dendritic cell fusions. Clin. Dev. Immunol. 2010, 516768 (2010).
15. Koido S, Hara E, Homma S et al. Synergistic induction of antigen-specific CTL by fusion of TLR-stimulated dendritic cells and heat-stressed tumor cells. J. Immunol. 179, 4874-4883 (2007).